FDA Issues Recall Alert for Metformin ER Products
The FDA is asking several pharmaceutical companies to voluntarily recall products containing extended-release formulations of metformin, a drug prescribed to millions of patients with type 2 diabetes.
Source: AAFP News - Category: Primary Care Source Type: news
More News: American Academy of Family Physicians (AAFP) | Diabetes | Diabetes Type 2 | Endocrinology | Fortamet | Metformin | Primary Care